GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » INVO Fertility Inc (NAS:IVF) » Definitions » Total Stockholders Equity

IVF (INVO Fertility) Total Stockholders Equity : $12.75 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is INVO Fertility Total Stockholders Equity?

INVO Fertility's Total Stockholders Equity for the quarter that ended in Dec. 2024 was $12.75 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. INVO Fertility's Book Value per Share for the quarter that ended in Dec. 2024 was $-47.26. The ratio of a company's debt over equity can be used to measure how leveraged this company is. INVO Fertility's Debt-to-Equity for the quarter that ended in Dec. 2024 was 0.78.

INVO Fertility Total Stockholders Equity Historical Data

The historical data trend for INVO Fertility's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

INVO Fertility Total Stockholders Equity Chart

INVO Fertility Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.74 7.31 -0.98 0.89 12.75

INVO Fertility Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.89 0.01 1.36 -0.02 12.75

INVO Fertility  (NAS:IVF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

INVO Fertility's Book Value per Share for the quarter that ended in Dec. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(12.747-30.375)/0.373
=-47.26

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

INVO Fertility's Debt-to-Equity for the quarter that ended in Dec. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(6.577 + 3.318) / 12.747
=0.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

INVO Fertility Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of INVO Fertility's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

INVO Fertility Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » INVO Fertility Inc (NAS:IVF) » Definitions » Total Stockholders Equity
Comparable Companies
AFIB TBIO ESMC DYNT HSDT ALRTF ODYY USAQ BJDX SONX ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
N/A
Address
5582 Broadcast Court, Sarasota, FL, USA, 34240
Website
https://www.invobioscience.com
INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body.
Executives
Trent D Davis director 811 SW NAITO PARKWAY, SUITE 200, PORTLAND OR 97204
Matthew K Szot director 802 NORTH DOUTY STREET, HANFORD CA 93230
Steve Shum director 9025 SW HILLMAN COURT, SUITE 3126, WILSONVILLE OR 97070
Andrea Goren officer: Chief Financial Officer 110 EAST 59TH STREET, SUITE 1901, NEW YORK NY 10022
Barbara Ryan director 22 CAVRAY ROAD, NORWALK CT 06855
Michael Jos. Campbell director 61 SOUTH HILLS DRIVE, BEDFORD NH 03110
Rebecca Messina director 5582 BROADCAST COURT, SARASOTA FL 34240
Jeffrey Segal director INVO BIOSCIENCE, INC., 5582 BROADCAST COURT, SARASOTA FL 34240
Awm Investment Company, Inc. 10 percent owner 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022
Kevin Doody director, officer: Medical Director 1109 SOMERSET BLVD, COLLEYVILLE TX 76034
Debra Robbins Hoopes officer: Acting CFO and PFO 1 MORTON DR., SUITE 200, CHARLOTTESVILLE VA 22903
Claude Ranoux 10 percent owner 8 CHESTNUT STREET, WINCHESTER MA 01890
Kathleen T Karloff director, officer: CEO/Chairman 109 BEACON STREET UNIT 5, BOSTON MA 02116
Bowdring Robert Joseph Jr officer: Chief Financial Officer 92 GOULD STREET, WAKEFIELD MA 01880